Read + Share
Sartori G, Tarantelli C, Spriano F, Gaudio E, et al. The ATR inhibitor elimusertib exhibits anti-lymphoma activity and synergizes with
the PI3K inhibitor copanlisib. Br J Haematol 2023 Nov 27. doi: 10.1111/bjh.19218.
PMID: 38011941
|
 |
|
Sartori G, Tarantelli C, Spriano F, Gaudio E, et al. The ATR inhibitor elimusertib exhibits anti-lymphoma activity and synergizes with
the PI3K inhibitor copanlisib. Br J Haematol 2023 Nov 27. doi: 10.1111/bjh.19218.
PMID: 38011941
|
|
|
|